Navigation Links
Vanda Pharmaceuticals, Inc. Sued by Investor
Date:7/7/2013

nth before study results were published that has allegedly never been used before in sleep-drug clinical trials, nor was it endorsed by the U.S. Federal Drug Administration.

Vanda Stock Price Falls Dramatically on Question of Validity of Clinic Trial for Tasimelteon

On June 19, 2013, The Street published an article casting doubt on the quality and efficacy of Vanda's clinical trial procedure and test data for tasimelteon.  In addition to the issues listed above, the article states that Vanda was forced to cut patient enrollment in the clinical trials in half because an insufficient number of totally blind patients with Non-24 could not be identified, and that ultimately less than 5% of the patients enrolled in the trials suffered from Non-24 according to the "textbook definition" of the disease.

On this news, Vanda shares declined $2.41 per share or more than 22%, to close at $8.51 per share on June 19, 2013.

If you invested in Vanda and would like to discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003, ddonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to http://www.robbinsarroyo.com.

Press release link:

SOURCE Robbins Arroyo LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
2. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
3. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
4. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
5. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
6. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
7. Vanda Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 2, 2012
8. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
9. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
10. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
11. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... in the upcoming Rodman & Renshaw 17 th ... in New York City .  Dr. ... a corporate overview on September 9, 2015. ...
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Pharmacovigilance (London, UK ... offering. Understanding PhV today - the ... working in Drug safety. This course ... with pharmacovigilance. New entrants as well as experienced ...
Breaking Medicine Technology:Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2
... N.J., March 17 Hereditary angioedema (HAE) is ... States each year. Patients with HAE suffer from ... skin, airway, and visceral organs. Left untreated, most ... per month. Chronic therapy with attenuated androgens or ...
... Surgeons to Lead Pivotal TrialANN ARBOR, Mich., March 17 ... appointed David Seth Feldman, MD/PhD, FACC, FAHA to be ... United States, studying the new, third generation DuraHeart(TM) Left ... Francis Pagani, Director of the Heart Transplant and Center ...
Cached Medicine Technology:Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies 2David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial 2David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial 3
(Date:9/4/2015)... , ... September 04, 2015 , ... Having access to ... has led to an increasing amount of unnecessary emergency room visits which affects hospitals’ ... taxes the country’s health bill. Fortunately, a solution to alleviate this problem has recently ...
(Date:9/4/2015)... ... September 04, 2015 , ... Lalonde Gordon ran a 44.64 seconds scorcher in ... in the men’s 400 meters final, with an impressive 44.89 seconds at the 2015 ... Jose, Costa Rica in August 2015. The 44.64 time is a new NACAC Championship ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance ... to settlements under the Stark physician self-referral law. “Stark Law DOs and ... from Atlantic Information Services, Inc. (AIS), will detail which deals are attracting the ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... Labor Day offer that cannot be passed up. FiltersFast.com, will ship all ... air and water filtration product replacements. Take advantage of this promotion now through ...
(Date:9/4/2015)... ... September 04, 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie ... of Hope event supporting families affected by autism, raising nearly $250,000. , 150 ... together at the Oscar Swan Inn to support the cause. , McCarthy tugged ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... Only about 75 percent of HIV/AIDS patients in the ... from the Perelman School of Medicine at the University of ... study of patients across the United States is the first ... and information about patients who are most likely to ...
... from Carnegie Mellon University,s Marcel Just provides an explanation ... communication disorders to restricted interests and gives scientists ... Autism has long been a scientific enigma, mainly due ... Published in the journal Neuroscience and Biobehavioral ...
... the journal Acta Obstetricia et Gynecologica Scandinavica reveals ... maternal or fetal indications increases the risk of cesarean section ... neonatal complications. Induction of labor is common and increasing ... are induced for "social" and other "non-recognized" reasons. Led ...
... Discoveries made in the laboratories of Sanford-Burnham Medical Research ... advance to the clinical research stage involving human studies ... for Metabolism and Diabetes (TRI). The research will focus ... which appears to resolve obesity without changes in food ...
... MONDAY, March 5 (HealthDay News) -- Some children who suffer ... memory problems, for many months, a new study finds. ... in childhood, with more than 500,000 children and teens a ... "The results of the study suggest that the majority ...
... researchers this week will announce the use of the ... curb post- traumatic stress disorder (PTSD)-related nightmares. In ... in Prague, Mayo Clinic psychiatrists will present a systematic ... Researchers investigated 12 prazosin studies, four of which were ...
Cached Medicine News:Health News:1 in 4 US HIV patients don't stay in care, Penn study shows 2Health News:1 in 4 US HIV patients don't stay in care, Penn study shows 3Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 2Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 3Health News:Unnecessary induction of labor increases risk of cesarean section and other complications 2Health News:Sanford-Burnham research advances to patient studies at TRI 2Health News:Sanford-Burnham research advances to patient studies at TRI 3Health News:Kids' Concussion Symptoms Can Last a Year, Study Says 2Health News:Mayo Clinic review: Blood pressure drug effective for treating PTSD-related nightmares 2
The XE-2100 automated hematology analyzer features new hematology parameters as NRBC, IRF, and HPC that offer valuable and accurate clinical information....
... The LH 750 analyzer ... NRBC enumeration and random access ... labs eliminate manual pre-sorting of ... clinicians. With this system, you ...
... infinity-corrected optical system for improved visibility and ... this one step further with the CKX41 ... capability of a fluorescence illuminator for GFP; ... video monitoring. The CKX41 is routinely used ...
... The CX41 continue ... of the CH2 microscopes ... arenas, now with UIS ... models improve all-around performance ...
Medicine Products: